Sjögren's Syndrome Market Research
What is Sjögren’s Syndrome (SjS)?
Sjögren’s syndrome (SjS) is an autoimmune disorder that affects the entire body, with symptoms consisting of excessive dryness (primarily in the eyes and mouth), along with fatigue, pain, and other major organ involvement. Individuals with other rheumatic diseases, such as rheumatoid arthritis (RA) or systemic lupus erythematosus (SLE) are more likely to develop SjS. About half of all SjS patients have also been diagnosed with another autoimmune disorder, classifying them as secondary SjS, whereas primary SjS occurs in the absence of another underlying rheumatic condition. SjS tends to affect women more often than men, and most patients develop the disorder after the age of 40. The primary symptoms include dry eyes and a dry mouth, though it can also be accompanied by symptoms such as dry skin, dry throat/nasal passages, joint pain, swelling of the salivary glands, numbness/tingling in areas such as the legs, muscle and joint pain, fatigue, shortness of breath, trouble sleeping, and skin rashes. In some cases, SjS can lead to vision problems such as blurred vision and damage to the corneas, dental issues such as cavities, and (though uncommon) damage to nerves, lymph nodes, the lungs, the kidneys, or the liver. Rheumatologists are dependent on use of many over the counter (OTC) products such as artificial tears, dry mouth products and lubricants as well as steroids, but do not have any approved options that treat the underlying disease of SjS. Those with neuropathy involvement rely on treatments like hydroxychloroquine and corticosteroids.
Spherix Global Insights – Rheumatology – Sjögren’s Syndrome (SjS)
Spherix Global Insights’ rheumatology therapeutic team is a leading provider of independent syndicated Sjögren’s syndrome market research, insights, business intelligence & advisory services.
Spherix’s rheumatology team publishes one (1) study in SjS:
- Market Dynamix™: Sjögren’s Syndrome (US)
Spherix’s Market Dynamix™ service includes analysis of markets anticipated to experience a paradigm shift within the next three to five years. Its insights highlight market size, current treatment approaches, unmet needs, and expert opinions on the likely disruption introduced by pipeline agents.
Follow Spherix Rheumatology on Social Media
For Guests & Current Clients
For more details on Spherix’s primary market research reports and interactive dashboard offerings, visit or register here: